| Trial ID: | L3447 |
| Source ID: | NCT00758927
|
| Associated Drug: |
Omega-3 Acid 4 Grams Per Day
|
| Title: |
The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Hypercholesterolemia|Hypertriglyceridemia
|
| Interventions: |
DRUG: Omega-3 acid 4 grams per day|DRUG: Placebo control
|
| Outcome Measures: |
Primary: Percentage change of plasma small dense LDL measured by ultracentrifuge-non denaturing polyacrylamide gel electrophoresis, April 2009 | Secondary: The percentage change of plasma HDL sub-fraction measured by ultracentrifuge-non denaturing polyacrylamide gel electrophoresis, April 2009
|
| Sponsor/Collaborators: |
Sponsor: Inje University | Collaborators: Kuhnil Pharmaceutical Co., Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
70
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-07
|
| Completion Date: |
2010-07
|
| Results First Posted: |
|
| Last Update Posted: |
2009-08-06
|
| Locations: |
Dong-A University Medical Center, Busan, 602-715, Korea, Republic of|Paik Diabetes Center, Busan, 614-735, Korea, Republic of|Endocrinology and Metabolism, Maryknoll General Hospital, Busan, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT00758927
|
